drugset / Trial / NCT06213233
MIVetsCan: Cannabidiol (CBD)-Care Trial
Phase 2
Recruiting
468 enrolled
Kevin Boehnke
Michigan, State of, Licensing and Regulatory Affairs · collab
RandomizedParallel-groupQuadruple-blindTreatment
Summary
This research is studying the effects of cannabidiol (CBD), an active component from cannabis (a.k.a. marijuana), on Veterans' chronic pain. The purpose of this study is to better understand if CBD can improve pain symptoms in Veterans with chronic pain. Eligible participants will be randomly assigned to receive either placebo medication (not active) or CBD during the study period. The study hypotheses: \- CBD would improve overall pain symptoms compared to placebo
Timeline
- Start
- 2024-02-12
- Primary completion
- 2028-12
- Completion
- 2028-12
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Cannabidiol | Other / unclassified | 0.2 ml | Oral |